182 related articles for article (PubMed ID: 29041854)
21. OnabotulinumtoxinA is Preferred over Sacral Neuromodulation for Refractory Overactive Bladder: Pro.
Ginsberg DA
J Urol; 2017 Jan; 197(1):11-13. PubMed ID: 27742453
[No Abstract] [Full Text] [Related]
22. Mirabegron: A new option in treating overactive bladder.
Turpen HC; Zimmern PE
JAAPA; 2015 Nov; 28(11):16, 18. PubMed ID: 26501573
[TBL] [Abstract][Full Text] [Related]
23. Drug therapy of overactive bladder--what is coming next?
Andersson KE
Korean J Urol; 2015 Oct; 56(10):673-9. PubMed ID: 26495067
[TBL] [Abstract][Full Text] [Related]
24. Overactive Bladder and the β3-Adrenoceptor Agonists: Current Strategy and Future Prospects.
Giarenis I; Robinson D; Cardozo L
Drugs; 2015 Oct; 75(15):1707-13. PubMed ID: 26323339
[TBL] [Abstract][Full Text] [Related]
25. A drug safety evaluation of mirabegron in the management of overactive bladder.
Robinson D; Thiagamoorthy G; Cardozo L
Expert Opin Drug Saf; 2016 May; 15(5):689-96. PubMed ID: 26980445
[TBL] [Abstract][Full Text] [Related]
26. Neuromodulative treatment with percutaneous tibial nerve stimulation for intractable detrusor instability: outcomes following a shortened 6-week protocol.
Yoong W; Ridout AE; Damodaram M; Dadswell R
BJU Int; 2010 Dec; 106(11):1673-6. PubMed ID: 20590544
[TBL] [Abstract][Full Text] [Related]
27. Overactive bladder syndrome - management and treatment options.
Arnold J; McLeod N; Thani-Gasalam R; Rashid P
Aust Fam Physician; 2012 Nov; 41(11):878-83. PubMed ID: 23145420
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of novel therapies for overactive bladder.
Mayr CA; Shepherd JP
Expert Rev Pharmacoecon Outcomes Res; 2014 Aug; 14(4):527-35. PubMed ID: 24809616
[TBL] [Abstract][Full Text] [Related]
29. Treatment of overactive bladder symptoms beyond antimuscarinics: current and future therapies.
Ellsworth P
Postgrad Med; 2012 May; 124(3):16-27. PubMed ID: 22691895
[TBL] [Abstract][Full Text] [Related]
30. Analgesia Using Transcutaneous Electric Nerve Stimulation in Office Bladder Chemodenervation, a Randomized Controlled Trial.
Hernandez-Aranda D; Panza J; Eigg M; Greenstein M; Li D; O'Brien J; Warren G; Doyle PJ
Urogynecology (Phila); 2024 May; 30(5):498-504. PubMed ID: 37930264
[TBL] [Abstract][Full Text] [Related]
31. The management of urinary incontinence in the male neurological patient.
Mehnert U; Kessler TM
Curr Opin Urol; 2014 Nov; 24(6):586-92. PubMed ID: 25389549
[TBL] [Abstract][Full Text] [Related]
32. Urgency after a sling: review of the management.
Abraham N; Vasavada S
Curr Urol Rep; 2014 Apr; 15(4):400. PubMed ID: 24515329
[TBL] [Abstract][Full Text] [Related]
33. Re: Urgency after a Sling: Review of the Management.
Wein AJ
J Urol; 2015 Sep; 194(3):728-9. PubMed ID: 26292865
[No Abstract] [Full Text] [Related]
34. Re: Urgency after a sling: review of the management.
Wein AJ
J Urol; 2015 Feb; 193(2):608. PubMed ID: 25617284
[No Abstract] [Full Text] [Related]
35. Overactive Bladder.
White N; Iglesia CB
Obstet Gynecol Clin North Am; 2016 Mar; 43(1):59-68. PubMed ID: 26880508
[TBL] [Abstract][Full Text] [Related]
36. Changing treatments for overactive bladder.
Waine E; Stott M
Nurs Times; 2008 Oct 14-20; 104(41):45-8. PubMed ID: 18979960
[TBL] [Abstract][Full Text] [Related]
37. [Overactive bladder syndrome--a public health challenge].
Veit-Rubin N; Meyer S; Achtari C
Rev Med Suisse; 2015 Oct; 11(492):2016-21. PubMed ID: 26672181
[TBL] [Abstract][Full Text] [Related]
38. New therapies in the treatment of overactive bladder.
Yeo EK; Hashim H; Abrams P
Expert Opin Emerg Drugs; 2013 Sep; 18(3):319-37. PubMed ID: 23885696
[TBL] [Abstract][Full Text] [Related]
39. Selective β₃-adrenoceptor agonists for the treatment of overactive bladder.
Andersson KE; Martin N; Nitti V
J Urol; 2013 Oct; 190(4):1173-80. PubMed ID: 23458471
[TBL] [Abstract][Full Text] [Related]
40. Sacral neuromodulation in patients with idiopathic overactive bladder after initial botulinum toxin therapy.
Smits MA; Oerlemans D; Marcelissen TA; Van Kerrebroeck PE; De Wachter SG
J Urol; 2013 Dec; 190(6):2148-52. PubMed ID: 23872028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
